Renu Virmani

Showing 1-20 of 31 articles

Detection of cholesterol crystals by optical coherence tomography

Jinnouchi H, Sato Y, Torii S, Sakamoto A, Cornelissen A, Bhoite R, Kuntz S, Guo L, Paek K, Fernandez R, Kolodgie F, Virmani R, Finn A

August 28, 2020 | 10.4244/EIJ-D-20-00202

Coronary interventions

Comparison of Acute Thrombogenicity and Albumin Adsorption in Three Different Durable Polymer Coronary Drug-Eluting Stents

Jinnouchi H, Kutyna M, Torii S, Cheng Q, Sakamoto A, Guo L, Cornelissen A, Perkins L, Hossainy SF, Pacetti S, Kolodgie F, Virmani R, Finn A

March 10, 2020 | 10.4244/EIJ-D-19-00938

Intracoronary imaging for the diagnosis of the underlying substrate and clinical management of acute coronary syndromes: from evidence to expert consensus … and back!

Alfonso F, Virmani R

August 29, 2019 | 10.4244/EIJV15I5A71

Coronary interventions

Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy

Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A, Guo L, Acampado E, Gupta A, Kolodgie F, Virmani R, Finn A

July 19, 2019 | 10.4244/EIJ-D-18-00740

Stents and scaffolds

Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents

Torii S, Cheng Q, Mori H, Lipinski M, Acampado E, Perkins L, Hossainy SF, Pacetti S, Kolodgie F, Virmani R, Finn A

March 20, 2019 | 10.4244/EIJ-D-17-00728

Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model

Lipinski M, Acampado E, Cheng Q, Adams L, Torii S, Gai J, Torguson R, Hellinga DG, Joner M, Harder C, Zumstein P, Finn A, Kolodgie F, Virmani R, Waksman R

January 18, 2019 | 10.4244/EIJ-D-17-00958

Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model

Foin N, Lu S, Ng J, Bulluck H, Hausenloy D, Wong P, Virmani R, Joner M

October 11, 2017 | 10.4244/EIJ-D-17-00381

Chemical sympathetic denervation: promising, but important distinctions between agents and methods

Bertog S, Vega F, Ghazarossian V, Pathak A, Vaskelyte L, Sievert H, Ladich E, Yahagi K, Virmani R

October 11, 2017 | 10.4244/EIJ-D-16-01000R

Interventions for valvular disease

Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration

Serruys P, Miyazaki Y, Katsikis A, Abdelghani M, Leon M, Virmani R, Carrel T, Cox M, Onuma Y, Soliman O

September 24, 2017 | 10.4244/EIJ-D-17-00509

Interventions for hypertension

Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model

Bertog S, Fischell T, Vega F, Ghazarossian V, Pathak A, Vaskelyte L, Kent D, Sievert H, Ladich E, Yahagi K, Virmani R

February 3, 2017 | 10.4244/EIJ-D-16-00206

Coronary interventions

Impact of local flow haemodynamics on atherosclerosis in coronary artery bifurcations

Antoniadis A, Giannopoulos A, Wentzel J, Joner M, Giannoglou G, Virmani R, Chatzizisis Y

May 19, 2015 | 10.4244/EIJV11SVA4

Coronary interventions

Pathological aspects of bioresorbable stent implantation

Sanchez O, Yahagi K, Byrne R, Mori H, Zarpak R, Wittchow E, Foin N, Virmani R, Joner M

May 19, 2015 | 10.4244/EIJV11SVA39

Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: a next-generation approach for treating sympathetic overactivity

Sakakura K, Roth A, Ladich E, Shen K, Coleman L, Joner M, Virmani R

February 20, 2015 | 10.4244/EIJY14M10_14

Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model

Vorpahl M, Nakano M, Perkins L, Otsuka M, Jones R, Acampado E, Lane J, Rapoza R, Kolodgie F, Virmani R

November 20, 2014 | 10.4244/EIJV10I7A143

Beta radiation for renal nerve denervation: initial feasibility and safety

Waksman R, Barbash I, Chan R, Randolph P, Makuria A, Virmani R

October 25, 2013 | 10.4244/EIJV9I6A118

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

Dani S, Costa R, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt S, Abizaid A

August 23, 2013 | 10.4244/EIJV9I4A79

Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter

Lemos P, Farooq V, Takimura C, Gutierrez P, Virmani R, Kolodgie F, Christians U, Kharlamov A, Doshi M, Sojitra P, van Beusekom H, Serruys P

May 21, 2013 | 10.4244/EIJV9I1A21

Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation

Steigerwald K, Ballke S, Quee S, Byrne R, Vorpahl M, Vogeser M, Kolodgie F, Virmani R, Joner M

October 26, 2012 | 10.4244/EIJV8I6A115

In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent

Yazdani S, Vorpahl M, Nakano M, Su S, Kolodgie F, Virmani R

November 30, 2011 | 10.4244/EIJV7I7A131

Paclitaxel-iopromide coated balloon followed by “bail-out” bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation

Milewski K, Tellez A, Aboodi M, Conditt G, Yi G, Thim T, Stenoien M, McGregor J, Gray W, Virmani R, Granada J, Kaluza G

July 29, 2011 | 10.4244/EIJV7I3A61

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers